clinical development AI platform
Search documents
Recursion Pharmaceuticals (NasdaqGS:RXRX) FY Conference Transcript
2026-01-13 19:32
Recursion Pharmaceuticals (NasdaqGS:RXRX) FY Conference January 13, 2026 01:30 PM ET Company ParticipantsNajat Khan - Chief R&D Officer and Chief Commercial OfficerBen Taylor - CFO and President of Recursion UKConference Call ParticipantsNone - AnalystModeratorHi, everyone. Let's get started. Welcome to the 44th Annual J.P. Morgan Healthcare Conference. My name is Priyanka Grover, and I'm part of the J.P. Morgan Biotech team. Today, our next presenting company is Recursion, and presenting on behalf of the c ...